Oppenheimer Initiates Coverage On Bioage Labs with Outperform Rating, Announces Price Target of $60
Benzinga Newsdesk 8 months ago
NewsPrice TargetInitiationAnalyst Ratings
Oppenheimer analyst Jay Olson initiates coverage on Bioage Labs (NASDAQ:BIOA) with a Outperform rating and announces Price Target of $60.
Oppenheimer analyst Jay Olson initiates coverage on Bioage Labs (NASDAQ:BIOA) with a Outperform rating and announces Price Target of $60.